Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
The closing price of Everus Construction Group (NYSE: ECG) was $84.11 for the day, down -5.73% from the previous closing price of $89.22. In other words, the price has decreased by -$5.73 from its previous closing price. On the day, 0.58 million shares were traded. ECG stock price reached its highest trading level at $89.7 during the session, while it also had its lowest trading level at $83.39.
Ratios:
Our analysis of ECG’s different ratios will help us gain a deeper understanding of the company. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 28.76 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 31.64. For the most recent quarter (mrq), Quick Ratio is recorded 1.69 and its Current Ratio is at 1.76. In the meantime, Its Debt-to-Equity ratio is 0.64 whereas as Long-Term Debt/Eq ratio is at 0.56.
Upgrades & Downgrades
In the most recent recommendation for this company, Oppenheimer on December 04, 2024, initiated with a Outperform rating and assigned the stock a target price of $70.
On November 15, 2024, Stifel started tracking the stock assigning a Buy rating and target price of $71.Stifel initiated its Buy rating on November 15, 2024, with a $71 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Dec 08 ’25 when Hernandez Helena Mercedes bought 250 shares for $92.18 per share. The transaction valued at 23,045 led to the insider holds 2,110 shares of the business.
Marcy Maximillian J bought 1,300 shares of ECG for $50,694 on Feb 25 ’25. The VP, CFO & Treasurer now owns 5,508 shares after completing the transaction at $38.99 per share. On Feb 25 ’25, another insider, Ryan Edward A, who serves as the Director of the company, bought 1,400 shares for $38.02 each. As a result, the insider paid 53,235 and bolstered with 14,928 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ECG now has a Market Capitalization of 4290163200 and an Enterprise Value of 4529856000. As of this moment, Everus’s Price-to-Earnings (P/E) ratio for their current fiscal year is 23.74, and their Forward P/E ratio for the next fiscal year is 21.21. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.38. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.23 while its Price-to-Book (P/B) ratio in mrq is 7.49. Its current Enterprise Value per Revenue stands at 1.296 whereas that against EBITDA is 16.78.
Stock Price History:
The Beta on a monthly basis for ECG is 3.83, which has changed by 0.3811146 over the last 52 weeks, in comparison to a change of 0.15905356 over the same period for the S&P500. Over the past 52 weeks, ECG has reached a high of $103.08, while it has fallen to a 52-week low of $31.38. The 50-Day Moving Average of the stock is -6.95%, while the 200-Day Moving Average is calculated to be 24.12%.
Shares Statistics:
ECG traded an average of 519.06K shares per day over the past three months and 615520 shares per day over the past ten days. A total of 51.01M shares are outstanding, with a floating share count of 50.83M. Insiders hold about 0.35% of the company’s shares, while institutions hold 84.60% stake in the company. Shares short for ECG as of 1764288000 were 1280552 with a Short Ratio of 2.47, compared to 1761868800 on 1742426. Therefore, it implies a Short% of Shares Outstanding of 1280552 and a Short% of Float of 3.27.
Earnings Estimates
The firm’s stock currently is rated by 3.0 analysts. The consensus estimate for the next quarter is $0.77, with high estimates of $0.84 and low estimates of $0.7.
Analysts are recommending an EPS of between $3.63 and $3.56 for the fiscal current year, implying an average EPS of $3.61. EPS for the following year is $3.93, with 4.0 analysts recommending between $4.2 and $3.63.
Revenue Estimates
It is expected that $90B in revenue will be generated in. The current quarter, according to 3 analysts. It ranges from a high estimate of $912M to a low estimate of $822.14M. As of. The current estimate, Everus Construction Group’s year-ago sales were $759.64MFor the next quarter, 3 analysts are estimating revenue of $885.15M. There is a high estimate of $889.31M for the next quarter, whereas the lowest estimate is $881M.
A total of 4 analysts have provided revenue estimates for ECG’s current fiscal year. The highest revenue estimate was $3.65B, while the lowest revenue estimate was $3.56B, resulting in an average revenue estimate of $3.6B. In the same quarter a year ago, actual revenue was $2.85BBased on 3 analysts’ estimates, the company’s revenue will be $3.86B in the next fiscal year. The high estimate is $3.9B and the low estimate is $3.82B.
